8th June 2026, Monday

TechPharus

Latest Posts

HealthTech News

  • Reducing side effects from breast cancer treatment
    on June 8, 2026 at 5:00 pm

    Most breast cancers are worsened by estrogens. To combat the recurrence of these cancers, clinicians treat patients with inhibitors for estrogen production, like letrozole. But many patients do not adhere to this treatment due to negative side effects.

  • A heritable ‘brake’ for stopping cocaine use in rats
    on June 8, 2026 at 5:00 pm

    Cocaine produces strong euphoric effects, but many users experience unpleasant effects after the rewarding aspects of the drug wear off, which serve as a “brake” for continued use. Research suggests that those who go on to misuse cocaine may not have as sensitive a natural brake on their use of the drug. Is there a genetic cause for this variability?

  • New evidence offers hope for ketogenic therapy in treatment of anorexia nervosa
    on June 8, 2026 at 5:00 pm

    A pilot study published today in Communications Medicine demonstrates the potential of a new approach to treating anorexia nervosa, a disorder for which effective treatments have been significantly limited. The research from UC San Diego School of Medicine reports that a ketogenic nutritional intervention—a high-fat, low-carbohydrate, moderate-protein diet—was feasible and safe for patients with weight-normalized and mildly underweight anorexia nervosa.

  • Rural patients at high risk for obstructive sleep apnea less likely to be referred for evaluation than urban patients
    on June 8, 2026 at 4:40 pm

    A new study to be presented at the SLEEP 2026 annual meeting found that patients at high risk for obstructive sleep apnea who receive primary care in rural settings are less likely to be referred for sleep apnea evaluation than those in urban areas, even after accounting for individual and neighborhood socioeconomic factors.

  • New map reveals how antidepressants reshape the brain’s serotonin system
    on June 8, 2026 at 4:40 pm

    A new study has uncovered how antidepressants affect different groups of serotonin-producing brain cells in opposite ways, offering new insights into why selective serotonin reuptake inhibitors (SSRIs) can cause unpleasant side effects at the start of treatment but lead to symptom relief over time.